BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 184 filers reported holding BRIDGEBIO PHARMA INC in Q3 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $43,562,715 | +82.2% | 2,532,716 | +75.6% | 0.05% | +73.3% |
| Q1 2023 | $23,915,523 | +580233.0% | 1,442,432 | +166.7% | 0.03% | +400.0% |
| Q4 2022 | $4,121 | -99.9% | 540,804 | +35.6% | 0.01% | 0.0% |
| Q3 2022 | $3,964,000 | +51.2% | 398,765 | +38.1% | 0.01% | +50.0% |
| Q2 2022 | $2,621,000 | +181.8% | 288,658 | +214.9% | 0.00% | +300.0% |
| Q1 2022 | $930,000 | -39.2% | 91,670 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $1,529,000 | -52.8% | 91,670 | +32.7% | 0.00% | -50.0% |
| Q3 2021 | $3,237,000 | – | 69,071 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 3,835,722 | $82,353,000 | 42.93% |
| Kohlberg Kravis Roberts & Co. L.P. | 36,900,661 | $792,257,000 | 4.46% |
| Perceptive Advisors | 6,706,268 | $143,983,000 | 3.88% |
| Cormorant Asset Management, LP | 2,617,566 | $56,199,000 | 3.42% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $571,553,000 | 2.98% |
| SC US (TTGP), LTD. | 2,544,738 | $54,636,000 | 2.42% |
| HHLR ADVISORS, LTD. | 4,388,690 | $94,225,000 | 1.30% |
| Fernwood Investment Management, LLC | 95,200 | $2,044,000 | 1.01% |
| AMERICAN INTERNATIONAL GROUP, INC. | 6,746,511 | $144,847,000 | 0.58% |
| Ratan Capital Management LP | 46,548 | $999,000 | 0.53% |